{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04024",
      "entity_text" : "pH3S10",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "uaz:UA-CLine-5317" ],
      "Species" : [ "taxonomy:9606" ],
      "Organ" : [ "uberon:UBERON:0006611" ]
    }
  },
  "verbose_text" : "The pH3T6, pH3S10 or pH3Y41 levels being markers of poor prognosis in GBM patients, we then asked the double question to know whether 1) the high level of pH3T6, pH3S10 or pH3Y41 are hallmarks associated with a phenotype of resistance to the standard treatment used in anti-GBM therapy (i.e. a treatment combining the temozolomide and the irradiation named TMZ+ Irrad treatment), and 2) the presence of this phenotype can be reverted by pre-treatment abolishing the presence of high levels of pH3T6, pH3S10 or pH3Y41.",
  "reading_complete" : "2020-08-03T13:57:56Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:56:08Z",
  "trigger" : "levels",
  "evidence" : [ "levels of pH3T6, pH3S10" ],
  "pmc_id" : "4265745",
  "score" : 0
}